Women excluded in clinical trials leaves treatment geared toward men

Historically, women have been underrepresented in clinical trials. Women make up over half of the population, but they only make up 30 percent of clinical trial patients. This can result in women being overmedicated because drug dosage trials are done on men. It can also lead to a lack of treatment for health issues predominantly found in women.